These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25988150)

  • 1. Differential effects of glycation on protein aggregation and amyloid formation.
    Iannuzzi C; Irace G; Sirangelo I
    Front Mol Biosci; 2014; 1():9. PubMed ID: 25988150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Role of Protein Glycation in the Amyloid Aggregation Process.
    Sirangelo I; Iannuzzi C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation induces formation of amyloid cross-beta structure in albumin.
    Bouma B; Kroon-Batenburg LM; Wu YP; Brünjes B; Posthuma G; Kranenburg O; de Groot PG; Voest EE; Gebbink MF
    J Biol Chem; 2003 Oct; 278(43):41810-9. PubMed ID: 12909637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical insights into protein misfolding and associated amyloidosis.
    Pande M; Srivastava R
    Eur J Med Chem; 2019 Dec; 184():111753. PubMed ID: 31622853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species.
    Iannuzzi C; Carafa V; Altucci L; Irace G; Borriello M; Vinciguerra R; Sirangelo I
    J Cell Physiol; 2015 Nov; 230(11):2807-20. PubMed ID: 25846844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sour side of neurodegenerative disorders: the effects of protein glycation.
    Vicente Miranda H; Outeiro TF
    J Pathol; 2010 May; 221(1):13-25. PubMed ID: 20186922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation in Demetalated Superoxide Dismutase 1 Prevents Amyloid Aggregation and Produces Cytotoxic Ages Adducts.
    Sirangelo I; Vella FM; Irace G; Manco G; Iannuzzi C
    Front Mol Biosci; 2016; 3():55. PubMed ID: 27695694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphenol binding disassembles glycation-modified bovine serum albumin amyloid fibrils.
    Prasanna G; Jing P
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Feb; 246():119001. PubMed ID: 33038859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide.
    Hsu YH; Chen YW; Wu MH; Tu LH
    Biophys J; 2019 Jun; 116(12):2304-2313. PubMed ID: 31155148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
    Jeffrey M
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the molecular mechanism of protein native-like aggregation upon glycation.
    Oliveira LM; Gomes RA; Yang D; Dennison SR; Família C; Lages A; Coelho AV; Murphy RM; Phoenix DA; Quintas A
    Biochim Biophys Acta; 2013 Jun; 1834(6):1010-22. PubMed ID: 23228929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of glycation in protein aggregation.
    Taghavi F; Habibi-Rezaei M; Amani M; Saboury AA; Moosavi-Movahedi AA
    Int J Biol Macromol; 2017 Jul; 100():67-74. PubMed ID: 26751401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in disease.
    Fonseca D; Gilberto S; Ribeiro-Silva C; Ribeiro R; Guinote IB; Saraiva S; Gomes RA; Mateus É; Viana A; Barroso E; Freire AP; Freire P; Cordeiro C; da Costa G
    Biochem J; 2016 Jul; 473(14):2225-37. PubMed ID: 27208169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational diseases: looking into the eyes.
    Surguchev A; Surguchov A
    Brain Res Bull; 2010 Jan; 81(1):12-24. PubMed ID: 19808079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloids: The History of Toxicity and Functionality.
    Yakupova EI; Bobyleva LG; Shumeyko SA; Vikhlyantsev IM; Bobylev AG
    Biology (Basel); 2021 May; 10(5):. PubMed ID: 34062910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein conformational diseases: from mechanisms to drug designs.
    Lin JC; Liu HL
    Curr Drug Discov Technol; 2006 Jun; 3(2):145-53. PubMed ID: 16925522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural effects of methylglyoxal glycation, a study on the model protein MNEI.
    Leone S; Fonderico J; Melchiorre C; Carpentieri A; Picone D
    Mol Cell Biochem; 2019 Jan; 451(1-2):165-171. PubMed ID: 30014221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.